These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 9221959)

  • 1. X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy.
    van Geel BM; Assies J; Wanders RJ; Barth PG
    J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):4-14. PubMed ID: 9221959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil".
    van Geel BM; Assies J; Haverkort EB; Koelman JH; Verbeeten B; Wanders RJ; Barth PG
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):290-9. PubMed ID: 10449548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.
    Aubourg P; Adamsbaum C; Lavallard-Rousseau MC; Rocchiccioli F; Cartier N; Jambaqué I; Jakobezak C; Lemaitre A; Boureau F; Wolf C
    N Engl J Med; 1993 Sep; 329(11):745-52. PubMed ID: 8350883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of X-linked adrenoleukodystrophy with Lorenzo's oil.
    Moser HW
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):279-80. PubMed ID: 10449544
    [No Abstract]   [Full Text] [Related]  

  • 5. Adrenoleukodystrophy: molecular genetics, pathology, and Lorenzo's oil.
    Moser HW; Powers JM; Smith KD
    Brain Pathol; 1995 Jul; 5(3):259-66. PubMed ID: 8520725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and red blood cell fatty acids in peroxisomal disorders.
    Moser AB; Jones DS; Raymond GV; Moser HW
    Neurochem Res; 1999 Feb; 24(2):187-97. PubMed ID: 9972864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary management of X-linked adrenoleukodystrophy.
    Moser HW; Borel J
    Annu Rev Nutr; 1995; 15():379-97. PubMed ID: 8527226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and genetic aspects of X-linked adrenoleukodystrophy.
    Gärtner J; Braun A; Holzinger A; Roerig P; Lenard HG; Roscher AA
    Neuropediatrics; 1998 Feb; 29(1):3-13. PubMed ID: 9553942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and therapeutic aspects of adrenoleukodystrophy and adrenomyeloneuropathy.
    Moser HW
    J Neuropathol Exp Neurol; 1995 Sep; 54(5):740-5. PubMed ID: 7666063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hexacosanoic and docosanoic acids plasma levels in patients with cerebral childhood and asymptomatic X-linked adrenoleukodystrophy: Lorenzo's oil effect.
    Deon M; Garcia MP; Sitta A; Barschak AG; Coelho DM; Schimit GO; Pigatto M; Jardim LB; Wajner M; Giugliani R; Vargas CR
    Metab Brain Dis; 2008 Mar; 23(1):43-9. PubMed ID: 18026827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of X-linked adrenoleukodystrophy.
    Semmler A; Köhler W; Jung HH; Weller M; Linnebank M
    Expert Rev Neurother; 2008 Sep; 8(9):1367-79. PubMed ID: 18759549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
    Kemp S; Valianpour F; Denis S; Ofman R; Sanders RJ; Mooyer P; Barth PG; Wanders RJ
    Mol Genet Metab; 2005 Feb; 84(2):144-51. PubMed ID: 15670720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lorenzo's oil: a reassessment.
    Poulos A; Robertson EF
    Med J Aust; 1994 Mar; 160(6):315-7. PubMed ID: 8133809
    [No Abstract]   [Full Text] [Related]  

  • 14. Komrower Lecture. Adrenoleukodystrophy: natural history, treatment and outcome.
    Moser HW
    J Inherit Metab Dis; 1995; 18(4):435-47. PubMed ID: 7494402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Lorenzo's oil" therapy for X-linked adrenoleukodystrophy: rationale and current assessment of efficacy.
    Moser HW; Moser AB; Hollandsworth K; Brereton NH; Raymond GV
    J Mol Neurosci; 2007 Sep; 33(1):105-13. PubMed ID: 17901554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the preventive effect of glyceryl trioleate-trierucate ("Lorenzo's oil") therapy in X-linked adrenoleukodystrophy: results of two concurrent trials.
    Moser HW; Raymond GV; Koehler W; Sokolowski P; Hanefeld F; Korenke GC; Green A; Loes DJ; Hunneman DH; Jones RO; Lu SE; Uziel G; Giros ML; Roels F
    Adv Exp Med Biol; 2003; 544():369-87. PubMed ID: 14713253
    [No Abstract]   [Full Text] [Related]  

  • 17. X-linked adrenoleukodystrophy.
    Moser HW; Mahmood A; Raymond GV
    Nat Clin Pract Neurol; 2007 Mar; 3(3):140-51. PubMed ID: 17342190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil.
    Poulos A; Gibson R; Sharp P; Beckman K; Grattan-Smith P
    Ann Neurol; 1994 Nov; 36(5):741-6. PubMed ID: 7979219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual evoked potentials in adrenoleukodystrophy: a trial with glycerol trioleate and Lorenzo oil.
    Kaplan PW; Tusa RJ; Shankroff J; Heller J; Moser HW
    Ann Neurol; 1993 Aug; 34(2):169-74. PubMed ID: 8338341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenoleukodystrophy: a link between adrenal insufficiency and school performance.
    Bakos JT; Goen P; Ogden A; Brown FR; Karaviti LP
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2869-72. PubMed ID: 7559867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.